Acelity Launches Telehealth Solution for the Home Care Setting Protection Status
Blog Category: 

By the WoundSource Editors

San Antonio, TX – October 26, 2016 – Acelity, a global wound care and regenerative medicine company, announced the launch of iOn PROGRESS™ Care Network with Remote Therapy Monitoring, a proprietary remote therapy monitoring system that delivers continuous at-home monitoring for patients prescribed negative pressure wound therapy (NPWT) in the home. The iOn PROGRESS™ technology enables timely feedback on patients' use of NPWT, as well as increased clinician interaction to assist with patient compliance.

iOn PROGRESS™ Remote Therapy Monitoring works in conjunction with the ACTIV.A.C.™ Therapy System, which was specifically developed for patients treated in the home. The ACTIV.A.C.™ Therapy System's lightweight, ergonomic design provides ease of use while the patented SENSAT.R.A.C.™ Technology, a real time pressure feedback system designed to deliver and maintain the prescribed negative pressure, provides optimal healing outcomes.

"V.A.C.® Therapy Systems are the leader in negative pressure wound therapy, and our focus is on expanding the technology with the dual aim of improving patient experience and reducing the overall cost of care," said Joe Woody, president and chief executive officer of Acelity. "We believe that by providing and supporting care in the optimal setting we can reduce the burden on patients as well as total costs; with the availability of the iOn PROGRESS™ Remote Therapy Monitoring, we move closer to our ultimate goal of achieving these care enhancements."

Remote therapy monitoring for wound care is particularly important for chronic wounds because compliance to prescribed therapy is a critical success factor for patients treated in the home. This new system is supported by the iOn PROGRESS™ Care Network, Acelity's highly-trained nursing professionals who can interact with patients to drive proper utilization. This helps to ensure patient care is accurately tracked and proactive intervention is achieved when necessary.

"Acelity has decades of expertise in wound therapy and the company is combining that experience with remote therapy monitoring in an attempt to efficiently reduce costs and improve outcomes for patients with chronic wounds," said Ron Silverman, M.D., FACS, chief medical officer of Acelity. "We aim to create a powerful continuous care model that enables early detection and prompt intervention that can improve clinical quality, patient satisfaction and cost containment. We see a critical opportunity to advance the science of wound care with solutions like iOn PROGRESS™ Remote Therapy Monitoring that can instill greater confidence with physicians when they send patients home to continue therapy."

Chronic wounds affect more than 6.5 million people in the U.S. each year and require constant treatment and attention.1 In fact, wound care treatment costs the U.S. more than $25 billion each year.2 Patients can be non-compliant for a variety of reasons and need support. When patients are non-compliant, it can lead to unnecessary spending for delayed healing, excessive hospital readmissions, which are a significant cost factor, as well as unnecessary emergency room visits. Many readmissions could possibly be prevented with improved postoperative monitoring and care.

Building upon this expanding platform, Acelity will soon initiate a pilot program for iOn RESULTS™ Remote Therapy Monitoring, which works in conjunction with the V.A.C.ULTA™ Therapy System to monitor the therapy units' performance in the hospital setting. iOn RESULTS™ Remote Therapy Monitoring will enable timely feedback and therapy application optimization to enhance product performance metrics and identify any hospital staff training or support needs, as well as support asset location and billing accuracy.

About Acelity
Acelity L.P. Inc. and its subsidiaries are a global advanced wound care and regenerative medicine company created by uniting the strengths of three companies, Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. Available in more than 80 countries, the innovative and complementary ACELITY™ product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs more than 5,800 people around the world.

1. Sen CK, Gordillo GM, Roy S, et al. Human Skin Wounds: A Major and Snowballing Threat to Public Health and the Economy. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2009;17(6):763-771.
2. Ibid.

Recommended for You

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.